Cargando…
Long non-coding RNAs in anti-cancer drug resistance
Chemotherapy is one of the basic treatments for cancers; however, drug resistance is mainly responsible for the failure of clinical treatment. The mechanism of drug resistance is complicated because of interaction among various factors including drug efflux, DNA damage repair, apoptosis and targets...
Autores principales: | Chen, Qin-nan, Wei, Chen-chen, Wang, Zhao-xia, Sun, Ming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5352108/ https://www.ncbi.nlm.nih.gov/pubmed/27713133 http://dx.doi.org/10.18632/oncotarget.12461 |
Ejemplares similares
-
Long non-coding RNAs regulate drug resistance in cancer
por: Liu, Kaisheng, et al.
Publicado: (2020) -
Long Non-Coding RNAs in Drug Resistance of Breast Cancer
por: Du, Tonghua, et al.
Publicado: (2020) -
Novel Implications of MicroRNAs, Long Non-coding RNAs and Circular RNAs in Drug Resistance of Esophageal Cancer
por: Wei, Ling, et al.
Publicado: (2021) -
Long non-coding RNAs: From disease code to drug role
por: Chen, Yuanyuan, et al.
Publicado: (2021) -
The role of exosomal long non-coding RNAs in cancer drug resistance
por: Cruz De los Santos, Mireia, et al.
Publicado: (2019)